In a mild TBI model, it was found that MW151 administration can inhibit acute cytokine upregulation (such as IL‐1β), protect glial cell responses (microglia and astrocytes), and alleviate downstream cognitive impairment [67]. The gene discussed is IL1B; the disease is Cognitive impairment.